Stock Taper
OPPORTUNITY RADAR SCREENER COMPARE ANY 2 STOCKS
DMIIR
DRUGS MADE IN AMERICA ACQUISITION II CORP.
NASDAQ
$0.07
▼ DOWN 11.07% (-0.01)

KEY STATISTICS

Market Cap$4.64 M
52w High$0.09
52w Low$0.07
Dividend Yield—
Frequency—
P/E—
Volume0
Shares Out.69.54M

COMPANY

LEADERSHIP

Roger Bendelac
CHIEF EXECUTIVE
Roger Bendelac

ABOUT

SECTOR
Financial Services
WENT PUBLIC
December 4, 2025
METHOD OF GOING PUBLIC
N/A
FULL TIME EMPLOYEES
2

PRICE

$0.07 ▼ DOWN 11.07% (−$0.01)
$0.07$0.08$0.0910:54 AM11:44 AM12:35 PM1:25 PM2:15 PM3:06 PM3:56 PM0.07

About Drugs Made In America Acquisition II Corp.

https://dmaacorp.com/ ↗

Drugs Made In America Acquisition II Corp., incorporated in 2024 in Fort Lauderdale, Florida, has no significant operations and aims to pursue a merger, acquisition, or similar business combination.

INDUSTRY

Financial - Conglomerates

A SERVICE DRUGS MADE IN AMERICA ACQUISITION II CORP. IS KNOWN FOR

Special Purpose Acquisition Company (SPAC) Investment Vehicle

Drugs Made In America Acquisition II Corp. is a SPAC that raises capital via IPO to acquire or merge with private U.S. pharmaceutical companies, without any current commercial operations.

COMPETITORS

COMPETITOR
ASPC COMPARE
HACQU COMPARE

RATINGS SNAPSHOT

Overall rating: A-

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity2
Return On Assets4
Debt To Equity4
Price To Earnings4
Price To Book5
Overall Score4